🇯🇵 Neulasta in Japan

PMDA authorised Neulasta on 26 September 2014

Marketing authorisation

PMDA — authorised 26 September 2014

  • Marketing authorisation holder: Kyowa Hakko Kirin Co., Ltd.
  • Status: approved

Neulasta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Japan

Frequently asked questions

Is Neulasta approved in Japan?

Yes. PMDA authorised it on 26 September 2014.

Who is the marketing authorisation holder for Neulasta in Japan?

Kyowa Hakko Kirin Co., Ltd. holds the Japanese marketing authorisation.